Cyprotex (LSE: CRX) announces that, at the Annual General Meeting held on Wednesday 1 June 2005, all the resolutions proposed were duly passed and the financial statements were approved.

Robert Morrisson Atwater, Chairman and CEO of Cyprotex Plc, said: "I would like to express my satisfaction with regards to the reorganisation of the Company in 2004. 2005 has started in line with management's best expectations.

"In addition, we are at an advanced stage of negotiations on a significant new contract with a major US biopharmaceutical group. This new deal would be in line with our aim to develop further, both geographically and by contract size."